Prostate Cancer Marker May Be Masked By Anti-Inflammatory Drugs

Chronic inflammation has been linked to a host of health issues including prostate cancer. New research suggests a significant correlation between use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen and reduced serum levels of the prostate biomarker, PSA (prostate specific antigen), making early detection of prostate cancer somewhat more risky.

Technorati Tags: inflammation, NSAID, prostate cancer, prostate specific antigen, PSA